NasdaqGM - Nasdaq Real Time Price
USD
Kodiak Sciences Inc. (KOD)
39.16
-3.66
(-8.54%)
As of 12:39:29 PM EDT. Market Open.
Trade KOD on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for KOD
- Previous Close
42.81 - Open
41.03 - Bid 30.22 x 200
- Ask 49.66 x 200
- Day's Range
38.70 - 42.20 - 52 Week Range
1.92 - 45.60 - Volume
770,163 - Avg. Volume
1,058,088 - Market Cap (intraday)
2.39B - Beta (5Y Monthly) 2.40
- PE Ratio (TTM)
-- - EPS (TTM)
-4.32 - Earnings Date (est.) May 13, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
51.67
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
kodiak.comRecent News: KOD
View More
Performance Overview: KOD
Trailing total returns as of 4/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
KOD
40.04%
S&P 500 (^GSPC)
4.22%
1-Year Return
KOD
1,366.48%
S&P 500 (^GSPC)
15.62%
3-Year Return
KOD
531.53%
S&P 500 (^GSPC)
59.56%
5-Year Return
KOD
64.11%
S&P 500 (^GSPC)
63.11%
Earnings Trends: KOD
View MoreAnalyst Insights: KOD
View MoreStatistics: KOD
View MoreValuation Measures
As of 4/1/2026
-
Market Cap
2.61B
-
Enterprise Value
2.46B
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
16.61
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-42.64%
-
Return on Equity (ttm)
-149.49%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-229.97M
-
Diluted EPS (ttm)
-4.32
Balance Sheet and Cash Flow
-
Total Cash (mrq)
209.86M
-
Total Debt/Equity (mrq)
37.60%
-
Levered Free Cash Flow (ttm)
-44.38M
Compare To: KOD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights: KOD
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
